Concepedia

H.H. Fiebig

HF

Statistics

Publications

20

Citations

987

H-Index

17

Active since

1986

Affiliations

University of Freiburg(Current)

University Medical Center Freiburg

European Organisation for Research and Treatment of Cancer

Western General Hospital

Universität Hamburg

H.H. Fiebig is an author at University of Freiburg specializing in medicine, pharmacology, and oncology.

Publications per year

1986–2009

20

Publications

20

BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.

C. Manzotti, Graziella Pratesi, E. MENTA et al. · PubMed · 2000 · 173 citations

, , +12

Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.

Markus Drees, W. A. Dengler, Thomas Roth et al. · PubMed · 1997 · 140 citations

, , +10

EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models

Hans R. Hendriks, P. E. Pizao, Dan Berger et al. · European Journal of Cancer · 1993 · 104 citations · Full text

, , +7

Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study.

Epie Boven, Benjamin Winograd, Delaney Berger et al. · PubMed · 1992 · 87 citations

, , +13

Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds

Sylvie M. Guichard, R. W. Else, Eilidh M. Reid et al. · Biochemical Pharmacology · 2005 · 77 citations

, , +9

1–5 of 20